Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

Beliefs and Practices Among Adults with Sickle Cell Disease Regarding Reproductive Health Decisions and Family Planning

Laura Ibidunni, Kristin Paulyson Nunez, MS, CGC, Jude C Jonassaint, RN, Laura De Castro, MD MHSc

Blood (2019) 134 (Supplement_1): 2101.

https://doi.org/10.1182/blood-2019-122255

Published: 2019

Journal Articles

Impact of Asthma on Inpatient Outcome of Sickle Cell Crisis: A Population-Based Study

Zimu Gong, MD PhD, Faisal Shaukat S Ali, MD, Yu Zhao, MD, Jessica Lee Garcia, MD

Blood (2019) 134 (Supplement_1): 4842.

https://doi.org/10.1182/blood-2019-132143

Published: 2019

Journal Articles

Feasibility of Peripheral Blood Stem Cell Collection from Heterozygoussickle Cell Trait Donors

Juergen Foell, MD, Morad Morez, Anja Troeger, MD, Katharina Kleinschmidt, MD PhD, Beatrix Pfirstinger, Andreas Brosig, MD PhD, Ralph Burkhardt, MD PhD, Selim Corbacioglu, MD, Norbert Ahrens

Blood (2019) 134 (Supplement_1): 1171.

https://doi.org/10.1182/blood-2019-131984

Published: 2019

Journal Articles

Effect of Marijuana Smoking Among Adult Sickle Cell Patients on Trends in Sickle Cell Crisis Hospitalizations and Acute Chest Syndrome: A Nationwide Inpatient Assessment

Shashank Sama, MBBS, Varun Tandon, Nikhila Kethireddy, Prajwal Boddu, MD

Blood (2019) 134 (Supplement_1): 4850.

https://doi.org/10.1182/blood-2019-122179

Published: 2019

Journal Articles

Evaluating Thrombocytopenia and Other Biomarkers in Multi-Organ Failure during Sickle Cell Crisis

Krithika Shanmugasundaram, MD, Ixavier Higgins, Fuad A El Rassi, MD, Morgan L. McLemore, MD

Blood (2019) 134 (Supplement_1): 4858.

https://doi.org/10.1182/blood-2019-122439

Published: 2019

Journal Articles

Safe Use of Hydroxyurea in Sickle Cell Disease Patients Hospitalized for Painful Vaso-Occlusive Episodes: Results of the Randomized, Open-Label Helps Study

Nicola Conran, PhD, Kleber Yotsumoto Fertrin, MD PhD, Claudia de Alvarenga Maximo, MD, Thais Oliveira, B.Sc., Clarisse Lobo, MD PhD, Fernando Ferreira Costa, MD PhD

Blood (2019) 134 (Supplement_1): 2303.

https://doi.org/10.1182/blood-2019-130106

Published: 2019

Journal Articles

Assessment of Sickle Cell Disease Pain Management in the Whittington Hospital Emergency Department

Leena Al Shaman, MD, Layan Akkielah, MD, Katharine Orf, MBBS, Jonathan Massie, MA, MBBS, Jiexin Zheng, MA, MBBS, MRCP, Farrukh Shah

Blood (2018) 132 (Supplement 1): 5822.

https://doi.org/10.1182/blood-2018-99-109768

Published: 2018

Journal Articles

Reduced Cerebrovascular Reserve Capacity in Adults with Sickle Cell Disease

Lena Vaclavu, MSc, Lena Vaclavu, Henri JMM Mutsaerts, PhD, Esben Thade Petersen, PhD, Ed T VanBavel, PhD, John C Wood, MD PhD, Charles BL Majoie, MD PhD, Aart J Nederveen, PhD, Bart J. Biemond, MD PhD

Blood (2017) 130 (Supplement 1): 972.

https://doi.org/10.1182/blood.V130.Suppl_1.972.972

Published: 2017

Journal Articles

Exploring Attitudes, Beliefs and Behavior Towards Hormonal Birth Control Among Female Patients with Sickle Cell Disease through Semi-Structured Interviews

Piper Kendra, PhD MPH1, Fuad El Rassi, MD, Morgan L. McLemore, MD, Melissa Kottke,

Blood (2017) 130 (Supplement 1): 4798.

https://doi.org/10.1182/blood.V130.Suppl_1.4798.4798

Published: 2017

Journal Articles

Supplemental Oxygen during Air Travel in Sickle Cell Disease -Common Clinical Practices

Amarjot Padda, BSc, Catherine Corriveau-Bourque, MD, Mark J. Belletrutti, MD MSc, Aisha Bruce, MD

Blood (2017) 130 (Supplement 1): 2079.

https://doi.org/10.1182/blood.V130.Suppl_1.2079.2079

Published: 2017

Journal Articles

Safety of Deferiprone in Individuals with Sickle Cell Disease

Janet L. Kwiatkowski, MD, Fernando Tricta, MD, Anna Rozova, MD

Blood (2017) 130 (Supplement 1): 2249.

https://doi.org/10.1182/blood.V130.Suppl_1.2249.2249

Published: 2017

Journal Articles

Contrary to Expectations: Seasonal Variation in Sickle Cell Crisis — a Nation Wide Data Analysis

Srinandan Guntupalli, MD

Blood (2017) 130 (Supplement 1): 3554.

https://doi.org/10.1182/blood.V130.Suppl_1.3554.3554

Published: 2017

Journal Articles

Safety and Tolerability of PF-04447943 across a Clinical Trial Program Including 277 Patients

Robert J Charnigo, MS, Beesan Tan, PhD, Denis Rybin, PhD, Debra D Pittman, MS, Krupa M. Sivamurthy, MBBS, MD, David Beidler, PhD, Nicholas Clarke, PhD

Blood (2017) 130 (Supplement 1): 3558.

https://doi.org/10.1182/blood.V130.Suppl_1.3558.3558

Published: 2017

Journal Articles

A New Measure Assessing Recovery from a Sickle Cell Crisis

Nicholas J. Vendetti, MS, Katy Benjamin, PhD, Olga Moshkovich, MPH, Kelly Lipman, MPH, Krupa M. Sivamurthy, MD DNB, Andreas M. Pleil, PhD

Blood (2016) 128 (22): 2392.

https://doi.org/10.1182/blood.V128.22.2392.2392

Published: 2016

Journal Articles

Microrna 221 Expression By Leukocytes Strongly Correlates with the Clinical Severity of Sickle Cell Disease

Iheanyi Okpala, FRCPath. FWACP., Ndubuisi Uwaezuoke, FMCPaed, Ifeoma Emodi, FMCPaed, Anthony Ikefuna, FMCPaed, Tagbo Oguonu, FMCPaed

Blood (2016) 128 (22): 2485.

https://doi.org/10.1182/blood.V128.22.2485.2485

Published: 2016

Journal Articles

Long-Term Dosing in Sickle Cell Disease Subjects with GBT440, a Novel HbS Polymerization Inhibitor

Josh Lehrer-Graiwer, MDMPhil, FACC, Jo Howard, MB, BChir, Claire Jane Hemmaway, MD, Moji Awogbade, Paul Telfer, FRCPath,MD, Mark Layton, MB, FRCP, John B. Porter, MD, Timothy Mant, MB, FFPM, FRCP, Kobina Dufu, PhD, Athiwat Hutchaleelaha, PhD, Donna Oksenberg, PhD, Mira Patel, PhD, Margaret Eleanor Tonda, PharmD, Kenneth Bridges, MD, Eleanor Ramos, MD

Blood (2016) 128 (22): 2488.

https://doi.org/10.1182/blood.V128.22.2488.2488

Published: 2016

Journal Articles

Hyperhaemolysis in Sickle Cell Disease Is Not Necessarily a Transfusion Reaction

Elizabeth A Jones, MB ChB MRCPCH FRCPath, Louise Smith, RCN MSc, Russell D Keenan, MB ChB, PhD FRCP, FRCPath

Blood (2015) 126 (23): 4595.

https://doi.org/10.1182/blood.V126.23.4595.4595

Published: 2015

Journal Articles

Acute Kidney Injury Is Prevalent Among Pediatric Admissions for Acute Chest Syndrome

Prasannalaxmi Palabindela, MBBS, Chanel Veasley, Thomas H. Howard, MD, Daniel Feig, MDPhDMS, David Askenazi, MDMSPH, Jeffrey D. Lebensburger, DO

Blood (2015) 126 (23): 3403.

https://doi.org/10.1182/blood.V126.23.3403.3403

Published: 2015

Journal Articles

Central Venous Access Device (CVAD) Use and Complications in Sickle Cell Disease Patients from Medicaid and Commercially-Insured U.S. Populations

Nancy Maserejian, ScD, Cortney Hayflinger, MS, Susan Eaton, MSPH, Catherine Madigan, MD, William E. Hobbs, MDPhD

Blood (2015) 126 (23): 2057.

https://doi.org/10.1182/blood.V126.23.2057.2057

Published: 2015

Journal Articles

Economic Impact of Sickle Cell Hospitalization

Rahul Singh, MD, Ryan Jordan, DO, Charin Hanlon, MD FACP

Blood (2014) 124 (21): 5971.

https://doi.org/10.1182/blood.V124.21.5971.5971

Published: 2014

NARROW

Beliefs and Practices Among Adults with Sickle Cell Disease Regarding Reproductive Health Decisions and Family Planning

Impact of Asthma on Inpatient Outcome of Sickle Cell Crisis: A Population-Based Study

Feasibility of Peripheral Blood Stem Cell Collection from Heterozygoussickle Cell Trait Donors

Effect of Marijuana Smoking Among Adult Sickle Cell Patients on Trends in Sickle Cell Crisis Hospitalizations and Acute Chest Syndrome: A Nationwide Inpatient Assessment

Evaluating Thrombocytopenia and Other Biomarkers in Multi-Organ Failure during Sickle Cell Crisis

Safe Use of Hydroxyurea in Sickle Cell Disease Patients Hospitalized for Painful Vaso-Occlusive Episodes: Results of the Randomized, Open-Label Helps Study

Assessment of Sickle Cell Disease Pain Management in the Whittington Hospital Emergency Department

Reduced Cerebrovascular Reserve Capacity in Adults with Sickle Cell Disease

Exploring Attitudes, Beliefs and Behavior Towards Hormonal Birth Control Among Female Patients with Sickle Cell Disease through Semi-Structured Interviews

Supplemental Oxygen during Air Travel in Sickle Cell Disease -Common Clinical Practices

Safety of Deferiprone in Individuals with Sickle Cell Disease

Contrary to Expectations: Seasonal Variation in Sickle Cell Crisis — a Nation Wide Data Analysis

Safety and Tolerability of PF-04447943 across a Clinical Trial Program Including 277 Patients

A New Measure Assessing Recovery from a Sickle Cell Crisis

Microrna 221 Expression By Leukocytes Strongly Correlates with the Clinical Severity of Sickle Cell Disease

Long-Term Dosing in Sickle Cell Disease Subjects with GBT440, a Novel HbS Polymerization Inhibitor

Hyperhaemolysis in Sickle Cell Disease Is Not Necessarily a Transfusion Reaction

Acute Kidney Injury Is Prevalent Among Pediatric Admissions for Acute Chest Syndrome

Central Venous Access Device (CVAD) Use and Complications in Sickle Cell Disease Patients from Medicaid and Commercially-Insured U.S. Populations

Economic Impact of Sickle Cell Hospitalization

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only